Palantir Bioceuticals

Palantir Bioceuticals EBITDA per Share

The EBITDA per Share of Palantir Bioceuticals (IFAN) as of Nov 3, 2026 is -0.03 USD.

EBITDA per Share

-0.03USD

YoY

4,956.15%

Last updated:

EBITDA per Share of Palantir Bioceuticals is 2015 -0.03 USD. EBITDA per Share of Palantir Bioceuticals was 2014 -0.00 USD. It decreases by 4,956.15% lower compared to the previous year.

The Palantir Bioceuticals EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2014
-0.00 USD
Jan 1, 2015
-0.03 USD
The Palantir Bioceuticals EBITDA per Share history
YEAREBITDA per ShareYoY
-0.03USD+4,956.15%
-0.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Palantir Bioceuticals Stock analysis

What does Palantir Bioceuticals do? IFAN Financial Inc is a company based in Las Vegas, Nevada. It originated in 1998 with the founding of iCARD Systems, specializing in prepaid cards. In 2007, the company changed its name to IFAN Financial Inc and expanded its business. The business model of IFAN Financial Inc focuses on providing financial services and technologies. The company specializes in various fields, including payment processing, mobile payment solutions, e-commerce, point-of-sale systems, and ethical investments. One important division of the company is IFAN Payment Systems, which offers a wide range of payment processing and payment solutions. The solutions can be used both online and offline. One particular feature is that IFAN Payment Systems provides fast transaction processing while maintaining high security standards. IFAN Financial Inc also has a division in the mobile services sector, which includes providing mobile payment solutions and mobile banking services. These services can be accessed through mobile devices and are tailored to the needs of modern customers who use mobile devices to manage and monitor their finances. Another important area in which IFAN Financial Inc operates is e-commerce. The focus is on providing technical solutions that allow customers to securely and effectively buy and sell goods and services online. The company has also developed a solution for online marketplaces, making it easier for merchants to register and sell on multiple platforms. The point-of-sale solutions of IFAN Financial Inc enable secure payments at retail terminals. The company offers a wide range of products, including POS hardware and POS software. These solutions are particularly designed to speed up transaction processing and increase customer satisfaction. Another important aspect of the company is ethical investing. IFAN Financial Inc advocates for ethical investments that have profit-oriented goals but do not come at the expense of other people or the environment. The company identifies investments that align with its portfolio of ethical investment products. Overall, IFAN Financial Inc has a wide portfolio of services and products tailored to the needs of customers. The company strives to provide customers with a secure and effective payment system that helps them manage their finances and optimize their businesses. The company has been in business since 1998 and thus has extensive experience in the financial sector. Palantir Bioceuticals is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Palantir Bioceuticals stock

EBITDA per Share of Palantir Bioceuticals is -0.03 USD in 2015.

On Eulerpool you can find the complete historical development of EBITDA per Share Palantir Bioceuticals since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Palantir Bioceuticals

All Key Metrics — Palantir Bioceuticals